| COGNITION THERAPEUTICS INC |
10%+ Owner |
Common Stock |
1,424,014 |
$1,495,215 |
$1.05 |
13 Oct 2021 |
Direct |
| COGNITION THERAPEUTICS INC |
10%+ Owner |
Series B-1 Convertible Preferred Stock |
0 |
|
|
13 Oct 2021 |
By Bios Fund III, LP. |
| COGNITION THERAPEUTICS INC |
10%+ Owner |
Series B-1 Convertible Preferred Stock |
0 |
|
|
13 Oct 2021 |
By Bios Fund III, NT, LP. |
| COGNITION THERAPEUTICS INC |
10%+ Owner |
Series B-1 Convertible Preferred Stock |
0 |
|
|
13 Oct 2021 |
By Bios Fund III, QP, LP. |
| COGNITION THERAPEUTICS INC |
10%+ Owner |
Series B-1 Convertible Preferred Stock |
0 |
|
|
13 Oct 2021 |
By Bios Fund II, LP. |
| COGNITION THERAPEUTICS INC |
10%+ Owner |
Series B-1 Convertible Preferred Stock |
0 |
|
|
13 Oct 2021 |
By Bios Fund II, NT, LP. |
| COGNITION THERAPEUTICS INC |
10%+ Owner |
Series B-1 Convertible Preferred Stock |
0 |
|
|
13 Oct 2021 |
By Bios Fund II, QP, LP. |
| COGNITION THERAPEUTICS INC |
10%+ Owner |
Series B-1 Convertible Preferred Stock |
0 |
|
|
13 Oct 2021 |
By Bios Memory SPV II, LP. |
| COGNITION THERAPEUTICS INC |
10%+ Owner |
Series B Convertible Preferred Stock |
0 |
|
|
13 Oct 2021 |
By Bios Fund I, LP. |
| COGNITION THERAPEUTICS INC |
10%+ Owner |
Series B Convertible Preferred Stock |
0 |
|
|
13 Oct 2021 |
By Bios Fund I, QP, LP. |
| COGNITION THERAPEUTICS INC |
10%+ Owner |
Series B Convertible Preferred Stock |
0 |
|
|
13 Oct 2021 |
Direct |
| COGNITION THERAPEUTICS INC |
10%+ Owner |
Simple Agreement for Future Equity |
0 |
|
|
13 Oct 2021 |
By Bios Fund III, LP. |
| COGNITION THERAPEUTICS INC |
10%+ Owner |
Simple Agreement for Future Equity |
0 |
|
|
13 Oct 2021 |
By Bios Fund III, NT, LP. |
| COGNITION THERAPEUTICS INC |
10%+ Owner |
Simple Agreement for Future Equity |
0 |
|
|
13 Oct 2021 |
By Bios Fund III, QP, LP. |
| COGNITION THERAPEUTICS INC |
10%+ Owner |
Warrant (right to buy) |
0 |
|
|
13 Oct 2021 |
By Bios Memory SPV II, LP. |